Diagnostic performance of mammography and ultrasound in breast cancer: a systematic review and meta-analysis

Tadesse, Getu Ferenji; Tegaw, Eyachew Misganew; Abdisa, Ejigu Kebede

doi:10.1007/s40477-022-00755-3

Cited by 7 publications

(1 citation statement)

References 49 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Implementing mammography screening in many countries for groups of women with an increased risk of breast cancer, that is, around the age of 50, was a breakthrough in streamlining the diagnostic process. Many studies have shown a significant decrease in the risk of breast cancer mortality after introducing mammography into medical practice [ 3 , 4 ]. However, imaging methods also have limitations.…”

Section: Introductionmentioning

confidence: 99%

CXC ELR-Positive Chemokines as Diagnostic and Prognostic Markers for Breast Cancer Patients

Motyka

Kicman

Kulesza

et al. 2023

Cancers

View full text Add to dashboard Cite

As the most common type of malignant lesison, breast cancer is a leading challenge for clinicians. Currently, diagnosis is based on self-examination and imaging studies that require confirmation by tissue biopsy. However, there are no easily accessible diagnostic tools that can serve as diagnostic and prognostic markers for breast cancer patients. One of the possible candidates for such markers is a group of chemokines that are closely implicated in each stage of tumorigenesis. Many researchers have noted the potential of this molecule group to become tumor markers and have tried to establish their clinical utility. In this work, we summarize the results obtained by scientists on the usefulness of the ELR-positive CXC group of chemokines in ancillary diagnosis of breast cancer.

show abstract

Section: Introductionmentioning

confidence: 99%